Valuation Prothena Corporation plc

Stocks

Market Closed - Nasdaq 16:00:00 2026-09-03 EDT			5-day change	1st Jan Change
9.600 ^USD	-0.88%		+5.61%	+0.52%

08-06	Tranche Update on Prothena Corporation plc's Equity Buyback Plan announced on February 27, 2026.	CI
08-06	Prothena Corporation plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,302	3,111	1,950	745.3	514.1	497.2	-	-
Change	-	35.14%	-37.3%	-61.79%	-31.02%	-3.28%	-	-
Enterprise Value (EV)	2,302	3,111	1,331	745.3	514.1	497.2	497.2	497.2
Change	-	35.14%	-57.2%	-44.02%	-31.02%	-3.28%	0%	0%
P/E	35.8x	-24.4x	-13.2x	-6.1x	-2.11x	88x	-10.4x	71.7x
PBR	-	-	3.44x	-	-	-	-	-
PEG	-	0x	-1.1x	0.3x	-0x	-1x	0x	-1x
Capitalization / Revenue	11.5x	57.7x	21.3x	5.51x	53.1x	5.98x	20.4x	4.92x
EV / Revenue	0x	0x	0x	0x	0x	5.98x	20.4x	4.92x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	0x	-0x	-0x	-0x	-0x	68.4x	-8.43x	162x
EV / FCF	0x	-	-0x	-0x	-0x	264x	-12.5x	5.85x
FCF Yield	4%	-	-7.01%	-20.2%	-31.8%	0.38%	-8.02%	17.1%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	1.38	-2.47	-2.76	-2.27	-4.53	0.11	-0.93	0.135
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	200.6	53.9	91.37	135.2	9.684	83.16	24.38	101.1
EBITDA	73.09	-	-190.1	-	-	-	-	-
EBIT ¹	71.98	-131.6	-191	-154.6	-214.6	7.27	-58.97	3.078
Net income ¹	66.98	-116.9	-147	-122.3	-244.1	6.224	-49.57	10.05
Net Debt	-	-	-618.8	-	-	-	-	-
Reference price ²	49.400	60.250	36.340	13.850	9.550	9.685	9.685	9.685
Nbr of stocks (in thousands)	46,594	51,627	53,665	53,809	53,830	51,337	-	-
Announcement Date	2/17/22	2/23/23	2/15/24	2/20/25	2/19/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
PROTHENA CORPORATION PLC	88.05x	-	-	-.--%	497M
WUXI APPTEC CO., LTD.	20.44x	7.17x	14.49x	1.43%	68.87B
ARGENX SE	37.07x	9.67x	29.5x	0.04%	65.29B
INSMED INCORPORATED	-77.51x	14.96x	-72.15x	-.--%	27.65B
WUXI BIOLOGICS (CAYMAN) INC.	29.76x	6.36x	16.52x	-.--%	25.77B
BIONTECH SE	-15.9x	6.16x	-7.74x	-.--%	26.08B
GENMAB A/S	27.51x	5.14x	17.12x	-.--%	20.14B
PHARMAESSENTIA CORPORATION	49.22x	18.16x	36.83x	0.31%	17.03B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1298.7x	37.56x	819.65x	-.--%	15.03B
EXELIXIS, INC.	18.08x	5.39x	12.58x	-.--%	14.5B
Average	147.54x	12.29x	96.31x	0.18%	28.09B
Weighted average by Cap.	82.78x	10.41x	52.16x	0.38%